血清lncRNA UCA1在食管鳞癌的表达及临床意义
Expression and clinical significance of serum lncRNA UCA1 in esophageal squamous cell carcinoma

DOI: 10.6040/j.issn.1671-7554.0.2018.178

Keywords: 食管鳞癌,诊断,监测,标志物,长链非编码RNA UCA1,
Biomarker,Monitoring,Long non-coding RNA UCA1,Diagnosis,Esophageal squamous cell carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	江楠, 田海华, 潘金昌, 等. 循环长链非编码RNA作为生物标志物在肿瘤分子诊断中应用[J].生物工程学报, 2017, 33(6): 910-922. JIANG Nan, TIAN Haihua, PAN Jinchang, et al. Circulating long noncoding RNAs as biomarkers in tumor diagnosis[J]. Chinese Journal of Biotechnology, 2017, 33(6): 910-922.
[2]	Xiao JN, Yan TH, Yu RM, et al. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression[J]. J Cancer Res Clin Oncol, 2017, 143(6): 981-990.
[3]	Duan W, Du L, Jiang X, et al. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer[J]. Oncotarget, 2016, 7(48): 78850-78858.
[4]	Wang W, He X, Zheng Z, et al. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma[J]. Mol Cancer, 2017, 16(1): 75. doi: 10.1186/s12943-017-0643-6.
[5]	Zheng ZK, Pang C, Yang Y, et al. Serum long noncoding RNA urothelial carcinoma-associated 1: a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma[J]. J Int Med Res, 2018, 46(1): 348-356.
[6]	Quinodoz S, Guttman M. Long noncoding RNAs: an emerging link between gene regulation and nuclear organization[J]. Trends Cell Biol, 2014, 24(11): 651-663.
[7]	Deniz E, Erman B. Long noncoding RNA(lincRNA), a new paradigm in gene expression control[J]. Funct Integr Genomics, 2017, 17(2-3): 135-143.
[8]	Tong YS, Wang XW, Zhou XL, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma[J]. Mol Cancer, 2015, 14: 3. doi: 10.1186/1476-4598-14-3.
[9]	Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(11): 7938-7944.
[10]	Yuan JH, Liu XN, Wang TT, et al. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1[J]. Nat Cell Biol, 2017, 19(7): 820-832.
[11]	Liu H, Wang G, Yang L, et al. Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/beta-catenin pathway[J]. PLoS One, 2016, 11(12): e0168406. doi: 10.1371/journal.pone.0168406.
[12]	Zuo ZK, Gong Y, Chen XH, et al. TGFbeta1-induced lncRNAUCA1 upregulation promotes gastric cancer invasion and migration[J]. DNA Cell Biol, 2017, 36(2): 159-167.
[13]	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[14]	Sakai NS, Samia-Aly E, Barbera M, et al. A review of the current understanding and clinical utility of miRNAs in esophageal cancer[J]. Semin Cancer Biol, 2013, 23(6 Pt B): 512-521.
[15]	Liao Y, Xing S, Xu B, et al. Evaluation of the circulating level of fibroblast activation protein alpha for diagnosis of esophageal squamous cell carcinoma[J]. Oncotarget, 2017, 8(18): 30050-30062.
[16]	Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma[J]. Clin Cancer Res, 2006, 12(16): 4851-4858.
[17]	Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1a(CUDR)promotes proliferation and tumorigenesis of bladder cancer[J]. Int J Oncol, 2012, 41(1): 276-284.
[18]	Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J]. Sci Rep, 2016, 6: 23892. doi: 10.1038/srep23892.
[19]	Wen JJ, Ma YD, Yang GS, et al. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma[J]. Eur Rev Med Pharmacol Sci, 2017, 21(3): 498-503.
[20]	Xia H, Ma L, Li J, et al. Elevated HBXIP expressionis associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma[J]. Am J Cancer Res, 2017, 7(11): 2190-2198.
[21]	Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6): 904-914.
[22]	Zhou Y, Wang X, Zhang J, et al. Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184[J]. Oncotarget, 2017, 8(11): 18260-18270.
[23]	Chen P, Wan D, Zheng D, et al. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer[J]. Biomed Pharmacother, 2016, 83: 1220-1226. doi: 10.1016/j.biopha.2016.08.041.
[24]	方海云, 高丰厚. 循环长链非编码RNA在消化道肿瘤中的研究进展[J].现代肿瘤医学, 2017, 25(13): 2160-2163. FANG Haiyun, GAO Fenghou. Research progress of long chain non coding RNA in digestive tract tumor[J]. Modern Oncology, 2017, 25(13): 2160-2163.
[25]	Hu HB, Jie HY, Zheng XX. Three circulating lncRNA predict early progress of esophageal squamous cell carcinoma[J]. Cell Physiol Biochem, 2016, 40(1-2):117-125.

Full-Text